78 related articles for article (PubMed ID: 8311158)
1. [The realization of the antiestrogen effect of tamoxifen in endometrial adenomatosis in women of reproductive age].
Putyrskaia NP; Chernukha GE
Akush Ginekol (Mosk); 1993; (6):43-6. PubMed ID: 8311158
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of the endometrial adenomatosis with tamoxifen in patients of reproductive age].
Smetnik VP; Chernukha GE; Kushlinskiĭ NE
Biull Eksp Biol Med; 1998 Jan; 125(1):93-7. PubMed ID: 9532378
[No Abstract] [Full Text] [Related]
3. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor expression in an endometrial stromal sarcoma after tamoxifen therapy.
Liao JB; Lin JY
Eur J Gynaecol Oncol; 2001; 22(6):417-9. PubMed ID: 11874071
[TBL] [Abstract][Full Text] [Related]
6. [The pathogenetic basis for using antiestrogens in treating patients with hyperplastic processes of the endometrium in the postmenopause].
Vysotskiĭ MM; Krasnova IA; Kostyleva OI; Eremin VL
Akush Ginekol (Mosk); 1993; (6):46-9. PubMed ID: 8311159
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
9. [The effect of danazol and tamoxifen on endometrial hyperplasia].
Soh E
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1612-22. PubMed ID: 2730056
[TBL] [Abstract][Full Text] [Related]
10. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical estrogen receptor assessment in hyperplastic, neoplastic, and physiologic endometria.
Huang SJ; Cheng L; Lewin KJ; Fu YS
Pathol Res Pract; 1991 May; 187(4):487-95. PubMed ID: 1876529
[TBL] [Abstract][Full Text] [Related]
13. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen and endometrial cancer.
Segna RA; Dottino PR; Deligdisch L; Cohen CJ
Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
[TBL] [Abstract][Full Text] [Related]
16. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
Schmidt D; Horn LC
Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
[TBL] [Abstract][Full Text] [Related]
17. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
19. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas].
Lang-Avérous G; Rupp K; Wehner H; Dallenbach-Hellweg G
Verh Dtsch Ges Pathol; 1991; 75():366-9. PubMed ID: 1724843
[TBL] [Abstract][Full Text] [Related]
20. [Morphologic endometrium changes with tamoxifen].
Dallenbach-Hellweg G; Hahn U; Schmidt D
Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
